Showing stories 1 - 10 of about 81
ARENA PHARMACEUTICALS, INC. : Arena Pharmaceuticals to Present at Two ...
Arena - Good Sales, Bad Sales, Long And Short Seeking Alpha
Related articles »
SAN DIEGO, May 24, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview at the following investor conferences: -- Deutsche Bank Securities 38(th) Annual ...
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): Why This Obesity ...
Insider Monkey (blog)Arena - Good Sales, Bad Sales, Long And Short Seeking Alpha
Related articles »
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Up 1.52%, Threshold ...
Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) opened trading at 5.34, 0.10 below its previous close of 5.44. Since the slow start THLD has rallied and is currently up 1.65% on volume of 158.36K - average volume is 597.61K.
NASDAQ Gainers Watch List: The Medicines Company (NASDAQ:MDCO) and ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) a biopharmaceutical company that engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system ...
Related articles »
Arena Pharmaceuticals, Inc. (ARNA): One Mind-Blowing Metric Screaming 'Buy'
Is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) an exceptional investment now? Prominent investors are taking a bullish view.
Option Bulls Jump on Arena Pharmaceuticals, Inc. (ARNA)
Arena Pharmaceuticals to Receive $65M in Milestone Payments from Eisai Inc. San Diego Business Journal
Related articles »
Bullish bets were unusually popular on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) yesterday, with call volume on the drug stock rising to more than three times the expected level.
ARENA PHARMACEUTICALS, INC. : Arena Pharmaceuticals Provides Update ...
4-traders (press release)Arena Pharmaceuticals to Receive $65M in Milestone Payments from Eisai Inc. San Diego Business Journal
Related articles »
Arena Pharmaceuticals, Inc. (ARNA), Vivus, Inc. (VVUS) & Orexigen ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) It wasn't that long ago that obesity drugs were considered a lifestyle drug.
Related articles »
Biopharma News: Arena Pharmaceuticals, Inc. (ARNA)'s Update, New VIVUS ...
Investors Alert: Arena Pharmaceuticals, Inc.(NASDAQ:ARNA), Mechel OAO, Michael Kors Holdings Ltd, DeVry Inc. (NYSE:DV) (SBWire) ThePennyStockProfiler, an investment community with a special focus on updating investors with recent news on the U.S.
Arena Pharmaceuticals, Inc. (ARNA): You Need To See These 5 Points
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) A sharp drop in Arena Pharmaceuticals (NASDAQ:ARNA) followed after the company reported quarterly earnings and a withdrawal of its Marketing Authorization Application (�MAA�) in the EU.
Related articles »
ARENA PHARMACEUTICALS, INC. : Arena Pharmaceuticals to Present at the ...
SAN DIEGO, May 10, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, ...
Related articles »
ARENA PHARMACEUTICALS, INC. : Arena Pharmaceuticals to Host Corporate ...
SAN DIEGO, April 26, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that it will provide a corporate update and discuss first quarter 2013 financial results after the NASDAQ Global Select Market closes on Thursday, ...
Related articles »